Aperturetx

1 known investors

Aperture Therapeutics uses machine learning to mine genomic and clinical datasets for naturally occurring protective gene variants, then designs oligonucleotide therapeutics that mimic those variants to treat neurodegenerative diseases such as ALS and FTD and delay brain aging. It targets shared drivers of both familial and sporadic disease, often related to neuroinflammation.